Using customized relational databases with the capacity to rapidly mine data and identify previously-unknown relationships, McCormack Pharma identifies free fatty acids as the final arbiter in determining the magnitude of clopidogrel resistance.
Using customized relational databases with the capacity to rapidly mine data and identify previously-unknown relationships, McCormack Pharma identifies free fatty acids as the final arbiter in determining the magnitude of clopidogrel resistance.